Jason Luoma, Ph.D., of Portland Psychotherapy, is the sponsor and Principal Investigator for SAMATI, an exploratory study to investigate the safety and preliminary efficacy of MDMA-assisted therapy for …
Historic Curated “Cartography of the Mind: A Curated NFT Sale” Auction is the First Time MAPS has Raised Money Using NFTs Beeple’s PILGRIMAGEPrice Realized: $252,000 Digital art, inspired by personal …
The FDA lifted the clinical hold from a MAPS-sponsored Phase 2 study of MDMA-assisted group therapy for the treatment of posttraumatic stress disorder among veterans at the VA Portland Health Care System …
On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated …
The Zendo Project Burning Man volunteer application deadline has been extended to June 24, 2022! To learn more and apply, visit the Zendo Project website.
Recruitment of participants has begun at our investigator-initiated trial at Portland Psychotherapy in Portland, Oregon. Dr. Jason Luoma and a team of researchers are conducting this study to assess the …
Training staff and contractors pictured above, from left to right: Sara Gael Giron, Corey Westbury, Veena Muthusamy, Nicole Sylvestre, Chris Stauffer, Ryan Beauregard, Wesley Hale, Christine Penny, Bruce …
In May 2022, over 1,100 donors gave $675,834 in donations and pledges to MAPS. We are so grateful to these supporters who advance our shared vision of creating safe and legal opportunities for the beneficial …
Study MJP2 protocol was initially submitted on March 9, 2021. The study was put on hold by FDA on May 10, 2021 with additional comments for the hold provided on June 3, 2021. MAPS provided FDA with a response …
Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access Appointment brings significant pharmaceutical leadership experience to the MAPS PBC board …
Christie’s is pleased to present Cartography of the Mind, a Curated NFT Sale to benefit the Multidisciplinary Association for Psychedelic Studies (MAPS) in collaboration with Ryan Zurrer, founder of …
Summary: Frontiers in Psychiatry discusses clinical considerations for route, dose, frequency, the importance of psychotherapy, and adverse events for ketamine for bipolar depression. Originally appearing …
